跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Tazopro
Approved
STANDARD
Tazopro
Reyoung Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d8c5251b6ee21517
Company
Reyoung Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
d8c5251b6ee21517
Drug Approval Philippines Name
Tazopro
Product Name
Tazopro
Registration Number
DRP-11462-03
Brand Name
Tazopro
Generic Name
Piperacillin (as sodium) + Tazobactam (as sodium)
Dosage Form
Powder for Injection (I.V.)
Dosage Strength
4 g/ 500 mg x
Manufacturer
Reyoung Pharmaceutical Co., Ltd
Importer
Sanimed Pharmaceuticals Inc.
Distributor
Medwise, Inc
Issuance Date
28 November 2022
Expiry Date
15 March 2027
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d8c5251b6ee21517
Type
Standard
Back to Philippines FDA Approvals
Tazopro - Philippines FDA Drug Approval Details